270 related articles for article (PubMed ID: 23440826)
41. Intermittent versus daily therapy for treating tuberculosis in children.
Bose A; Kalita S; Rose W; Tharyan P
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD007953. PubMed ID: 24470141
[TBL] [Abstract][Full Text] [Related]
42. Fluoroquinolones for treating tuberculosis (presumed drug-sensitive).
Ziganshina LE; Titarenko AF; Davies GR
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD004795. PubMed ID: 23744519
[TBL] [Abstract][Full Text] [Related]
43. Isoniazid for preventing tuberculosis in HIV-infected children.
Zunza M; Gray DM; Young T; Cotton M; Zar HJ
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD006418. PubMed ID: 28850172
[TBL] [Abstract][Full Text] [Related]
44. Antibiotics for bronchiolitis in children under two years of age.
Farley R; Spurling GK; Eriksson L; Del Mar CB
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005189. PubMed ID: 25300167
[TBL] [Abstract][Full Text] [Related]
45. Lymphadenitis caused by infection with an isoniazid- and rifampin-resistant strain of Mycobacterium bovis BCG in an infant with IFN-γ/IL-12 pathway defect.
Diniz LM; Guimarães T; Oliveira Md; Pinto JA; Miranda SS
J Bras Pneumol; 2014; 40(2):188-92. PubMed ID: 24831405
[TBL] [Abstract][Full Text] [Related]
46. Three-month weekly rifapentine plus isoniazid for tuberculosis preventive treatment: a systematic review.
Hamada Y; Ford N; Schenkel K; Getahun H
Int J Tuberc Lung Dis; 2018 Dec; 22(12):1422-1428. PubMed ID: 30606313
[TBL] [Abstract][Full Text] [Related]
47. Routine surgery in addition to chemotherapy for treating spinal tuberculosis.
Jutte PC; Van Loenhout-Rooyackers JH
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004532. PubMed ID: 16437489
[TBL] [Abstract][Full Text] [Related]
48. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis.
Abubakar I; Pimpin L; Ariti C; Beynon R; Mangtani P; Sterne JA; Fine PE; Smith PG; Lipman M; Elliman D; Watson JM; Drumright LN; Whiting PF; Vynnycky E; Rodrigues LC
Health Technol Assess; 2013 Sep; 17(37):1-372, v-vi. PubMed ID: 24021245
[TBL] [Abstract][Full Text] [Related]
49. Clinical characteristics and needle aspiration management of Bacillus Calmette-Guérin lymphadenitis in children.
Suliman OM; Ahmed MJ; Bilal JA
Saudi Med J; 2015 Mar; 36(3):280-5. PubMed ID: 25737168
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of chemoprophylaxis and immunoprophylaxis in leprosy prevention: a systematic review and network meta-analysis of randomized controlled trials.
Tawfik GM; Biala M; Yousef YM; Tiwari R; Dobs M; Lotfy CI; Farrag DA; Hue AT; Yotsu RR; Huy NT
Clin Microbiol Infect; 2021 Dec; 27(12):1754-1761. PubMed ID: 34332107
[TBL] [Abstract][Full Text] [Related]
51. BCG lymphadenitis: a potential complication of immune reconstitution following haematopoietic stem cell transplant.
Tsilifis C; Schim van der Loeff I; Williams E; Owens S; Powell S; Gennery A; Slatter M
Arch Dis Child Educ Pract Ed; 2022 Aug; 107(4):274-275. PubMed ID: 33355234
[TBL] [Abstract][Full Text] [Related]
52. Severe BCG immune reconstitution inflammatory syndrome lymphadenitis successfully managed with pre-antiretroviral counseling and a non-surgical approach: a case report.
Machava P; Joaquim W; Borrell J; Richardson S; Cassia U; Sidat M; Maieca A; Massitela C; Quelhas Y; Mucuila C; Elias B; da Rocha M; Schaaf HS; Buck WC
AIDS Res Ther; 2024 Apr; 21(1):25. PubMed ID: 38678293
[TBL] [Abstract][Full Text] [Related]
53. Bacillus Calmette-Guérin vaccine-related complications in children in Oman.
Al Waili B; Al Mufarajii N; Al Hashmi S; Al Ajmi A; Al Sukaiti N
Ann Saudi Med; 2021; 41(1):24-30. PubMed ID: 33550906
[TBL] [Abstract][Full Text] [Related]
54. Clinical, Microbiological Profile and Treatment Outcomes of Infants with BCG Adenitis: A Retrospective Study.
Dash N; Verghese VP; Rose W; Michael JS; Rebekah G; Venkatesan M; Chacko A
J Trop Pediatr; 2022 Oct; 68(6):. PubMed ID: 36370459
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis.
Ayieko J; Abuogi L; Simchowitz B; Bukusi EA; Smith AH; Reingold A
BMC Infect Dis; 2014 Feb; 14():91. PubMed ID: 24555539
[TBL] [Abstract][Full Text] [Related]
56. Prosthetic joint infection: an extremely rare complication of intravesicular BCG therapy.
Storandt M; Nagpal A
BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31826907
[TBL] [Abstract][Full Text] [Related]
57. First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world.
Lu J; Zhang X; Xu H; Li Z
Hum Vaccin Immunother; 2022 Nov; 18(5):2080443. PubMed ID: 35687363
[TBL] [Abstract][Full Text] [Related]
58. Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults.
Hatherill M; Geldenhuys H; Pienaar B; Suliman S; Chheng P; Debanne SM; Hoft DF; Boom WH; Hanekom WA; Johnson JL
Vaccine; 2014 Jun; 32(31):3982-8. PubMed ID: 24814553
[TBL] [Abstract][Full Text] [Related]
59. The spectrum of cytological findings in patients with BCG lymphadenitis: A series of 13 cases.
Vaghasiya VL; Nasit JG; Rupavatiya B; Bambhaniya DD; Kaka R
Ann Diagn Pathol; 2024 Apr; 69():152260. PubMed ID: 38171232
[TBL] [Abstract][Full Text] [Related]
60. CLINICAL MANAGEMENT OF LOCALIZED BCG ADVERSE EVENTS IN CHILDREN.
Moreira TN; Moraes-Pinto MI; Costa-Carvalho BT; Grumach AS; Weckx LY
Rev Inst Med Trop Sao Paulo; 2016 Nov; 58():84. PubMed ID: 27828625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
